Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: Multicenter International Durability and Safety of Sirolimus in LAM Trial (MIDAS)
Brief Summary: The MIDAS study aims to follow women with LAM who are currently taking, have previously failed or been intolerant of, or are considering treatment with mTOR inhibitors sirolimus or everolimus as part of their clinical care.